What we’re reading, October 26, 2016: AAP advises that parents take measures to reduce the risk of SIDS; Republican presidential nominee Donald Trump reacts to ACA premium hikes announced by HHS; patients with ALS volunteer for an accelerated study on the effects of a dietary supplement.
The American Academy of Pediatrics (AAP) has issued an updated set of guidelines meant to lower the risk of sudden infant death syndrome (SIDS). It specifies that infants should ideally sleep in the same room as their parents for the first 6 to 12 months of their lives, but they should sleep in their own crib with only a fitted sheet on the mattress. The report also cautions that exhausted parents can often fall asleep on a couch or rocking chair after feeding the baby, which poses a high risk of suffocation.
The announcement that Affordable Care Act (ACA) premiums will rise an average of 22% in 2017 drew criticism from Republican presidential nominee Donald Trump during a speech in which he seemingly contradicted himself regarding his employees’ health insurance. After proclaiming that “all of [his] employees are having a tremendous problem with Obamacare,” he later said that they “don’t even use Obamacare. We don’t want it.” Trump has repeatedly called to repeal the ACA and replace it with something “much less expensive.”
50 patients with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) have volunteered to take part in a streamlined study to test the potential effects of the dietary supplement lunacin. The protocols for this study, which does not include a control group receiving a placebo, are considerably less rigorous than those of a traditional clinical trial because the researchers want to quickly observe any promising effects the supplement may have. Participants are likewise enthusiastic about the accelerated pace of the trial and their ability to easily report their symptoms online.
Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending
August 19th 2025Hospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Read More
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More